Patients who are identified as having a nutritional deficiency should have a comprehensive nutritional screening coupled with early treatment, with a low threshold to supplement thiamine in addition to B12
The role of Akkermansia muciniphila in T2D and related diseases Typical manifestations of diabetes include obesity, insulin resistance, impaired glucose tolerance, abnormal lipid metabolism, and low-grade systemic inflammation (Weir and Bonner-Weir, 2004)
Solutions are far less stable than powders and are usually recommended for use within a short timeframe
These drugs bind to the GLP-1 receptor and: Lower blood sugar by increasing insulin and reducing glucagon Slow gastric emptying Reduce appetite and food cravings Support clinically significant weight loss in many people They are commonly prescribed for: Type 2 diabetes Obesity or overweight with weight-related health risks Trials suggest GLP-1 agonists can reduce body weight by around 5 to 18 per cent on average, often with improvements in blood pressure, cholesterol and other cardiometabolic markers
A small RCT (n=21) found that inhaled glutathione (600 mg twice daily for 3 months) modestly improved some pulmonary function parameters (Griese et al., Am J Respir Crit Care Med, 2004) [47]